Profile picture

Doctor Mansoor Husain

University of Toronto, Toronto (Canada)
Membership: ESC Professional Member
Follow
Biography
Dr. Mansoor Husain is Executive Director of the Ted Rogers Centre for Heart Research and Professor of Medicine at University of Toronto. He is an Attending Staff Cardiologist at the University Health Network where he works in the cardiac intensive care unit, nuclear cardiology, and ambulatory cardiology. Dr. Husain was the gold medallist in Medicine at University of Alberta, completed his clinical training at University of Toronto, and undertook post-doctoral training in the Program of Excellence in Cardiovascular Biology at Massachusetts Institute of Technology. His research aims to elucidate the molecular bases of cardiovascular diseases such as hypertension, atherosclerosis and heart failure, with a particular emphasis on identifying therapeutic targets involved in pathophysiology. Dr. Husain’s bench-to-bedside work has improved our understanding of the cardiovascular mechanisms of glucagon-like peptide-1 and related anti-diabetic drugs.
Logo ESC

Contributor content

Cardiovascular effects of glucagon-like peptide 1 receptor agonists.
Presentation
Cardiovascular effects of glucagon-like peptide 1 receptor agonists.
GLP-1 and the cardiovascular system
Presentation
GLP-1 and the cardiovascular system
Arrythmias and heart rate increase in the LEADER trial and relation to risk of cardiovascular events
Presentation
Arrythmias and heart rate increase in the LEADER trial and relation to risk of cardiovascular events
Connect with the speakers: questions & answers.
Presentation
Connect with the speakers: questions & answers.
Aligning treatment barriers with practical considerations.
Presentation
Aligning treatment barriers with practical considerations.
Interactive discussions - GLP-1 receptor agonists and CV risk management in type 2 diabetes: a new treatment paradigm?
Presentation
Interactive discussions - GLP-1 receptor agonists and CV risk management in type 2 diabetes: a new treatment paradigm?
Results from the LEADER cardiovascular outcomes trial.
Presentation
Results from the LEADER cardiovascular outcomes trial.
Cardiovascular outcomes trials in diabetes – What have we learned?
Presentation
Cardiovascular outcomes trials in diabetes – What have we learned?

ESC 365 is supported by